SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination

CELL RESEARCH

SPRINGERNATURE

1. Netherlands Organisation for Scientific Research [91719300]
2. Dutch Cancer Society [10140]
3. China Scholarship Council [201808370170]
4. ZonMw COVID project [114025011]